- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02673788
Follow-Up Study of Safety of Pneumostem® in Premature Infants With Intraventricular Hemorrhage
April 7, 2019 updated by: Won Soon Park, Samsung Medical Center
This is a follow-up study of the open label, single-center, phase I clinical trial to evaluate the safety of Pneumostem® in premature infants with Intraventricular hemorrhage.
Study Overview
Status
Active, not recruiting
Intervention / Treatment
Study Type
Observational
Enrollment (Anticipated)
9
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Seoul, Korea, Republic of
- Samsung Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
6 months to 2 years (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Paitents who enrolled in the previous phase 1 clinical trial of Pneumostem transplantation for IVH.
Description
Inclusion Criteria:
- Patients who enrolled in the previous phase 1 clinical trial of Pneumostem transplantation for IVH.
Exclusion Criteria:
- Patients who did not enrolled in the previous phase 1 clinical trial of Pneumostem transplantation for IVH.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
newly developed brain tumor
Time Frame: until 2 years old (corrected age)
|
Using brain MRI, it is to assess the risk of tumorigenicity of donor stem cells.
|
until 2 years old (corrected age)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Bayley score (MDI, PDI)
Time Frame: until 2 years old (corrected age)
|
until 2 years old (corrected age)
|
|
Cerebral palsy
Time Frame: until 2 years old (corrected age)
|
more than score 2 based on Gross Motor Function Classification System (GMFCS) score
|
until 2 years old (corrected age)
|
Developmental disability
Time Frame: until 2 years old (corrected age)
|
scoring (category: gait, sitting, hand use, head control, communication, vision, hearing)
|
until 2 years old (corrected age)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2016
Primary Completion (Anticipated)
December 1, 2022
Study Completion (Anticipated)
December 1, 2023
Study Registration Dates
First Submitted
January 26, 2016
First Submitted That Met QC Criteria
February 1, 2016
First Posted (Estimate)
February 4, 2016
Study Record Updates
Last Update Posted (Actual)
April 9, 2019
Last Update Submitted That Met QC Criteria
April 7, 2019
Last Verified
April 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2015-09-102
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Intracranial Hemorrhages
-
King's College Hospital NHS TrustActive, not recruitingStroke | Intracranial Hemorrhages | Brain AneurysmUnited Kingdom
-
Fondation Ophtalmologique Adolphe de RothschildActive, not recruitingPatients' Follow-up After Subarachnoid Haemorrhage Caused by Ruptured Intracranial Aneurysms (FUSAC)Intracranial AneurysmsFrance
-
NoNO Inc.WithdrawnSubarachnoid Hemorrhage | Ruptured Intracranial AneurysmCanada, United States
-
Walton Centre NHS Foundation TrustUniversity of Liverpool; National Institute for Health Research, United KingdomNot yet recruitingTiming to Restart Direct Oral Anticoagulants After Traumatic Intracranial Haemorrhage (RESTARTtlCrH)Traumatic Intracranial Haemorrhage
-
McMaster UniversityCanadian Institutes of Health Research (CIHR)CompletedTraumatic Intracranial HaemorrhageCanada
-
McMaster UniversityCanadian Institutes of Health Research (CIHR)UnknownTraumatic Intracranial HaemorrhageCanada
-
Alexion Pharmaceuticals, Inc.CompletedAcute Intracranial HemorrhageCanada, Denmark, Italy, Netherlands, Spain, United States, Belgium, Switzerland, Germany, Hungary, Russian Federation, Czechia, France, United Kingdom, Israel, Austria, Norway, Latvia, Finland, Poland, Sweden, Portugal, Greece, Lithuania
-
Centre hospitalier de l'Université de Montréal...RecruitingIntracranial Hemorrhage Ruptured AneurysmUnited States, Canada, Spain
-
Henry Ford Health SystemUnknownSubarachnoid Hemorrhage | Vasospasm, Intracranial | Cerebral AneurysmUnited States
-
University of California, Los AngelesCompletedSubarachnoid Hemorrhage | Subarachnoid Hemorrhage, Aneurysmal | Cerebral Vasospasm | Intracranial AneurysmUnited States
Clinical Trials on observation without intervention in this follow up study
-
Göteborg UniversityCompletedAtrial FibrillationSweden
-
Shandong Provincial HospitalRecruitingBrain Aging Related ConditionsChina
-
Helsinki University Central HospitalCentral Finland Central HospitalCompletedSepsis | Acute Kidney Injury | Critically Ill | OliguriaFinland
-
National Taiwan University HospitalCompleted
-
Steba Biotech S.A.ICON plc; International Drug Development InstituteCompletedCancer of the ProstateNetherlands, Spain, France, Germany, United Kingdom, Finland, Italy, Sweden
-
Sheffield Teaching Hospitals NHS Foundation TrustRecruitingMolar Incisor HypomineralisationUnited Kingdom
-
Hospital Italiano de Buenos AiresCompletedBacterial Infections | Cirrhosis | Morality | Resistant InfectionArgentina
-
Second Affiliated Hospital, School of Medicine,...RecruitingLocked-In Syndrome;Pulmonary Arteriovenous MalformationChina
-
Johannes Gutenberg University MainzWithdrawn
-
Shanghai 10th People's HospitalUnknownBlood Pressure | Cardiovascular Risk Factor | Overall Mortality | Cardiovascular Mortality | Cardiovascular Events | Target Organ DamageChina